Patient-level medication regimen complexity across populations with chronic disease.

PubWeight™: 1.24‹?› | Rank: Top 10%

🔗 View Article (PMID 23541707)

Published in Clin Ther on March 29, 2013

Authors

Anne M Libby1, Douglas N Fish, Patrick W Hosokawa, Sunny A Linnebur, Kelli R Metz, Kavita V Nair, Joseph J Saseen, Joseph P Vande Griend, Sara P Vu, Jan D Hirsch

Author Affiliations

1: Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA. anne.libby@ucdenver.edu

Articles citing this

Drug-drug interaction software in clinical practice: a systematic review. Eur J Clin Pharmacol (2014) 0.89

Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenet Genomics (2014) 0.87

Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infect Dis Ther (2016) 0.86

One-Year Mortality in Older Patients with Cancer: Development and External Validation of an MNA-Based Prognostic Score. PLoS One (2016) 0.83

Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularity. Int J Bipolar Disord (2013) 0.82

Medication regimen complexity in kidney and liver transplant recipients. Transplantation (2014) 0.80

Medication Regimen Complexity and Number of Medications as Factors Associated With Unplanned Hospitalizations in Older People: A Population-based Cohort Study. J Gerontol A Biol Sci Med Sci (2015) 0.79

Total daily pill burden in HIV-infected patients in the southern United States. AIDS Patient Care STDS (2014) 0.79

Prevalence and Access of Secondary Source Medication Data: Evaluation of the Southeastern Diabetes Initiative (SEDI). AMIA Jt Summits Transl Sci Proc (2015) 0.79

Factors associated with medication regimen complexity in older people: a cross-sectional population-based study. Eur J Clin Pharmacol (2015) 0.78

Anticoagulated patient's perception of their illness, their beliefs about the anticoagulant therapy prescribed and the relationship with adherence: impact of novel oral anticoagulant therapy - study protocol for The Switching Study: a prospective cohort study. BMC Hematol (2016) 0.78

Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention. Pharmacotherapy (2014) 0.77

Once-weekly albiglutide in the management of type 2 diabetes: patient considerations. Patient Prefer Adherence (2014) 0.76

Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease. SAGE Open Med (2016) 0.76

Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease. Dig Dis Sci (2016) 0.75

Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol. Patient Prefer Adherence (2015) 0.75

Medication regimen complexity in ambulatory older adults with heart failure. Clin Interv Aging (2017) 0.75

Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge. BMC Cardiovasc Disord (2014) 0.75

Medication regimen complexity in adults and the elderly in a primary healthcare setting: determination of high and low complexities. Pharm Pract (Granada) (2015) 0.75

Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk. J Clin Endocrinol Metab (2015) 0.75

Articles by these authors

American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice. Pharmacotherapy (2006) 9.72

Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm (2013) 5.02

National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother (2004) 2.40

Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy (2005) 2.11

Time of day is associated with postoperative morbidity: an analysis of the national surgical quality improvement program data. Ann Surg (2008) 2.00

Unscheduled readmissions to the PICU: epidemiology, risk factors, and variation among centers. Pediatr Crit Care Med (2013) 1.99

Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension (2011) 1.95

Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol (2008) 1.88

A strategy to develop advanced pharmacy practice experiences. Am J Pharm Educ (2007) 1.86

Assessing renal function in cirrhotic patients: problems and pitfalls. Am J Kidney Dis (2003) 1.74

A randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawal. Crit Care Med (2014) 1.66

Pharmacy practice, research, education, and advocacy for older adults. Pharmacotherapy (2005) 1.64

Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) (2013) 1.60

Race and surgical outcomes: it is not all black and white. Ann Surg (2008) 1.48

Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006. Antimicrob Agents Chemother (2009) 1.47

Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia. Ann Pharmacother (2012) 1.39

Perceptions of disease and health-related quality of life among patients with gout. Rheumatology (Oxford) (2009) 1.27

Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions. Clin Interv Aging (2010) 1.25

Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey. Patient Prefer Adherence (2011) 1.17

Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit. Pharmacotherapy (2002) 1.11

FDA drug safety communications: a narrative review and clinical considerations for older adults. Am J Geriatr Pharmacother (2012) 1.07

Waterpipe smoking among health sciences university students in Iran: perceptions, practices and patterns of use. BMC Res Notes (2011) 1.03

Suggested guidelines for pharmacotherapy curricula in family medicine residency training: recommendations from the Society of Teachers of Family Medicine Group on Pharmacotherapy. Fam Med (2005) 1.02

Comparison of patient characteristics and gout-related health-care resource utilization and costs in patients with frequent versus infrequent gouty arthritis attacks. Rheumatology (Oxford) (2012) 1.01

Stability of phenylephrine hydrochloride injection in polypropylene syringes. Am J Health Syst Pharm (2007) 0.99

Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother (2007) 0.99

Evaluation of bivalirudin treatment for heparin-induced thrombocytopenia in critically ill patients with hepatic and/or renal dysfunction. Pharmacotherapy (2006) 0.96

Quetiapine for insomnia: A review of the literature. Am J Health Syst Pharm (2014) 0.95

Vitreous penetration of orally administered valacyclovir. Am J Ophthalmol (2008) 0.94

Older adults with multi-morbidity: medication management processes and design implications for personal health applications. J Med Internet Res (2011) 0.94

Levofloxacin pharmacokinetics and pharmacodynamics in patients with severe burn injury. Antimicrob Agents Chemother (2006) 0.92

Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies. J Eval Clin Pract (2010) 0.92

The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Am J Manag Care (2005) 0.91

Caring for patients with chronic kidney disease: a joint opinion of the ambulatory care and the nephrology practice and research networks of the American College of Clinical Pharmacy. Pharmacotherapy (2005) 0.91

A retrospective cohort study of correlates of response to pharmacologic therapy for hyperlipidemia in members of a managed care organization. Clin Ther (2003) 0.90

Report of the 2009-2010 Professional Affairs Committee: pharmacist integration in primary care and the role of academic pharmacy. Am J Pharm Educ (2010) 0.90

Impact of the women's health initiative trial results on hormone replacement therapy. Pharmacotherapy (2004) 0.90

Diagnosis and management of osteoporosis in the older senior. Clin Interv Aging (2009) 0.90

Vasopressin, not octreotide, may be beneficial in the treatment of hepatorenal syndrome: a retrospective study. Nephrol Dial Transplant (2005) 0.89

Development of a pharmacist-psychiatrist collaborative medication therapy management clinic. J Am Pharm Assoc (2003) (2012) 0.88

Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia. Pharmacotherapy (2005) 0.88

Enteral glutamine supplementation in critically ill patients with burn injuries: a retrospective case-control evaluation. Pharmacotherapy (2007) 0.87

Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Ann Pharmacother (2009) 0.87

Categorization of infliximab dose changes and healthcare utilization and expenditures for patients with rheumatoid arthritis in commercially insured and Medicare-eligible populations. Curr Med Res Opin (2009) 0.87

Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Am J Cardiovasc Drugs (2015) 0.86

Consumer-driven health plans: impact on utilization and expenditures for chronic disease sufferers. J Occup Environ Med (2009) 0.86

Minimally important differences of the gout impact scale in a randomized controlled trial. Rheumatology (Oxford) (2011) 0.86

Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr (2008) 0.86

A multifaceted intervention to implement guidelines did not affect hospitalization rates for nursing home-acquired pneumonia. J Am Med Dir Assoc (2010) 0.84

Clinical pharmacists as key members of the patient-centered medical home: an opinion statement of the Ambulatory Care Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy (2013) 0.84

Association between glycated hemoglobin and health utility for Type 1 diabetes. Patient (2014) 0.84

Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation. Pharmacotherapy (2012) 0.84

Evaluating sample medications in primary care: a practice-based research network study. Jt Comm J Qual Patient Saf (2006) 0.84

Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition. JPEN J Parenter Enteral Nutr (2007) 0.84

Utilization characteristics of spinal interventions. Spine J (2011) 0.84

The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costs. J Occup Environ Med (2013) 0.84

Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother (2004) 0.84

Vitreous penetration of orally administered famciclovir. Am J Ophthalmol (2009) 0.84

Determining predictors of response to exenatide in type 2 diabetes. J Am Pharm Assoc (2003) (2012) 0.84

Impact of a multidisciplinary intervention on antibiotic use for nursing home-acquired pneumonia. Am J Geriatr Pharmacother (2011) 0.83

Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients. Pharmacotherapy (2008) 0.83

Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes. J Am Pharm Assoc (2003) (2013) 0.82

Comparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care plan. J Health Care Finance (2011) 0.82

Navigating complex patients using an innovative tool: the MTM Spider Web. J Am Pharm Assoc (2003) (2013) 0.82

Venlafaxine-associated vaginal bleeding. Pharmacotherapy (2002) 0.82

Efflux pump contribution to multidrug resistance in clinical isolates of Pseudomonas aeruginosa. Pharmacotherapy (2010) 0.82

Predictors of doctor-rated and patient-rated gout severity: gout impact scales improve assessment. J Eval Clin Pract (2010) 0.82

Pharmacokinetics and safety of valaciclovir in children with Epstein-Barr virus illness. Drugs R D (2002) 0.82

Toward prospective identification of high-risk surgical patients. Am Surg (2012) 0.82

Management of extravasation injuries: a focused evaluation of noncytotoxic medications. Pharmacotherapy (2014) 0.81

Probable levetiracetam-associated depression in the elderly: two case reports. Am J Geriatr Pharmacother (2009) 0.81

An off-site clinical pharmacy service in family medicine: development and 1-year outcomes. Fam Med (2014) 0.81

Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions. Pharmacotherapy (2012) 0.81

Adherence to statins in primary prevention: yearly adherence changes and outcomes. J Manag Care Pharm (2014) 0.80

Treatment of hepatorenal syndrome. Pharmacotherapy (2009) 0.80

Inconsistencies in opioid equianalgesic ratios: clinical and research implications. J Pain Palliat Care Pharmacother (2008) 0.80

Prescription co-pay reduction program for diabetic employees. Popul Health Manag (2010) 0.79

A year in review: new drugs for older adults in 2011. Am J Geriatr Pharmacother (2012) 0.79

Evaluation of preemptive valdecoxib therapy on initial archwire placement discomfort in adults. Angle Orthod (2006) 0.79

Evidence for long-term use of intramuscular interferon beta-1a: an overview of relapse, disability, and MRI data from selected clinical trials. J Manag Care Pharm (2013) 0.79

Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans. Am J Manag Care (2004) 0.79

Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy (2010) 0.79

Evaluation of type 2 diabetes mellitus medication management and control in older adults. Consult Pharm (2013) 0.78

Emerging methods for evaluating the effectiveness of intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis. J Manag Care Pharm (2013) 0.78

Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag (2013) 0.78

Reliability and accuracy of practitioner-calculated Acute Physiology and Chronic Health Evaluation II scores for determining the appropriateness of drotrecogin alfa (activated). Am J Health Syst Pharm (2010) 0.78

Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists. J Am Pharm Assoc (2003) (2011) 0.78

Acyclovir concentrations in human breast milk after valaciclovir administration. Am J Obstet Gynecol (2002) 0.78

Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients. Pharmacotherapy (2013) 0.78

Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients. J Clin Lipidol (2009) 0.78

The impact of genetic polymorphisms, diltiazem, and demographic variables on everolimus trough concentrations in lung transplant recipients. Clin Transplant (2014) 0.77

Validation of a patient-level medication regimen complexity index as a possible tool to identify patients for medication therapy management intervention. Pharmacotherapy (2014) 0.77

Effects of continuous vasopressin infusion in patients with septic shock. Ann Pharmacother (2004) 0.77